Literature DB >> 7584077

Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene.

A N Shelling1, M G Smith.   

Abstract

Human adeno-associated virus (AAV) integrates specifically into a site (AAVS1) on chromosome 19q13.3-qter. We report that both transfected and infected AAV-vectors will target a foreign gene preferentially to AAVS1. Of 11 infected cell lines studied, nine (82%) showed integration of the neomycin resistance marker into AAVS1, which confirms the findings of previous investigations. We also show site-specific integration (nine out of 12 cell lines, 75%) following transfection of an AAV vector containing the neomycin gene. The ability of transfected AAV sequences to preferentially target and express selectable genes at a known site in the human genome extends the potential use of AAV as a vector in gene therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7584077

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  32 in total

Review 1.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system.

Authors:  P Meneses; K I Berns; E Winocour
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates.

Authors:  M D Davis; J Wu; R A Owens
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Authors:  A Recchia; R J Parks; S Lamartina; C Toniatti; L Pieroni; F Palombo; G Ciliberto; F L Graham; R Cortese; N La Monica; S Colloca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size.

Authors:  G E Tullis; T Shenk
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.

Authors:  D Rinaudo; S Lamartina; G Roscilli; G Ciliberto; C Toniatti
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome.

Authors:  R T Surosky; M Urabe; S G Godwin; S A McQuiston; G J Kurtzman; K Ozawa; G Natsoulis
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro.

Authors:  M D Davis; R S Wonderling; S L Walker; R A Owens
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets.

Authors:  P Wu; M I Phillips; J Bui; E F Terwilliger
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Development of animal models for adeno-associated virus site-specific integration.

Authors:  G Rizzuto; B Gorgoni; M Cappelletti; D Lazzaro; I Gloaguen; V Poli; A Sgura; D Cimini; G Ciliberto; R Cortese; E Fattori; N La Monica
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.